Skip to main content
High RiskFDAfda-F-2062-2012UNDECLARED ALLERGEN

HORNBACHERS, FRENCH VANILLA ICE CREAM, Half-gallon (1.89 L), 0 41130 21658 9 (Missing Egg in the Contains statement)

Category
Units Affected
0
Recall Date
July 20, 2012
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2062-2012.

Cass-Clay Creamery is voluntarily recalling a number of ice cream products because labelling of egg ingredient is not FALCPA compliant.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2062-2012.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Cass Clay Creamery Ampi Fargo Division or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2062-2012.

Cass Clay Creamery AMPI Fargo Division

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Cass Clay Creamery Ampi Fargo Division Recall FAQ

Cass Clay Creamery Ampi Fargo Division is the subject of a dairy safety report: HORNBACHERS, FRENCH VANILLA ICE CREAM, Half-gallon (1.89 L), 0 41130 21658 9 (Missing Egg in the Contains statement). The notice was published on July 20, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.